Mundipharma
Michael Sapurmas is a seasoned sales professional with extensive experience in the pharmaceutical industry. Currently serving as Sales Manager at Mundipharma Australia since March 2018, Michael focuses on Urology, Oncology, and Haematology. Michael also holds the position of National Sales Manager ANZ at Tolmar Australia Pty Ltd since May 2015, having previously worked as a Product Specialist Representative in Urology at Tolmar Australia starting in December 2013. Prior roles include Product Specialist Representative at Hospira from January 2007 to December 2013 and Specialist Representative at Wyeth from January 1999 to November 2006.
This person is not in any teams
This person is not in any offices
Mundipharma
5 followers
The Mundipharma global network of independent associated companies shares a common purpose to identify and accelerate the development of meaningful medicines that add value for patients and healthcare providers around the globe. Founded in the US by two physicians in 1952 and still privately owned, the network has a presence in over 120 countries. In Europe, the network employees more than 2,000 employees from R&D to manufacturing & supply and commercial, and with revenues in excess of €1 billion. At Mundipharma we strive for one high performing and learning environment where individuals can make a real difference. We have a strong track record of building successful alliances to license, develop and market medicines that improve patients’ lives, while also providing attractive options to financially constrained healthcare systems. Consistent with our entrepreneurial heritage, we like to think that we see what others don’t by challenging conventional wisdom and asking different and challenging questions. By working in partnership with all our stakeholders, the Mundipharma network develops medicines that create value for patients, payers and wider healthcare systems. We have built a European portfolio of medicines to create value for patients, payers and wider healthcare systems across important therapeutic areas such as diabetes, respiratory, oncology, pain and biosimilars.